Position in NAMS
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$82,105
New position
Shares Held
2,565
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026AdvisorNet Financial, Inc holds $2,790,551 across 42 Biotechnology names. NAMS ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,864 | $1,278,890 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
8,003 | $380,702 | |
| 3 | INCY |
Incyte Corp
|
3,132 | $294,783 | |
| 4 | TECH |
BIO-TECHNE Corp
|
4,055 | $211,914 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135 | $104,306 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
2,565 | $82,105 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
1,620 | $53,816 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
171 | $44,172 |
All Filings in NAMS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,105 | 2,565 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||